Skip to main content
Premium Trial:

Request an Annual Quote

WuXi NextCode Sequencing Facility Receives CAP Accreditation

NEW YORK (GenomeWeb) –WuXi AppTec subsidiary WuXi NextCode said today that its sequencing facility in Shanghai, China has been accredited by the College of American Pathologists.

The company also said that the Shanghai lab is the first such lab in China to be licensed by the State of California, allowing the company to process samples from the state. WuXi NextCode is also the only sequencing facility in China with CLIA certification from the US Centers for Medicare and Medicaid, the company said.

"Our system is the emerging global standard for querying, storing and collaborating with genomic data," WuXi NextCode COO Hannes Smarason said in a statement. "The CAP, CLIA and California accreditation of our sequencing lab ... [enables] us to provide products and services to more customers and to the most demanding standards in every market."